Results 231 to 240 of about 2,266,569 (385)
After the intravenous injection of biomimetic and pH/ROS‐responsive PTSK@CRM, the nanoparticles can be accumulated in tumors and release Sim and KYNase to inhibit the tumor growth, regulate the metabolism of cholesterol and Kyn, and reverse the immunosuppressive tumor microenvironment.
Jiaxin Yin +6 more
wiley +1 more source
Acetaminophen interactions with immune checkpoint inhibitors: guilt by association? [PDF]
de Lemos ML +4 more
europepmc +1 more source
Heterogeneous cancer‐associated fibroblasts orchestrate dual immune microenvironments in LAGC. Abstract The potential for immunotherapy in patients with locally advanced gastric cancer (LAGC) is recently confirmed. To report the 3‐year follow‐up data are aimed from a novel clinical trial. This is a prospective single‐arm phase II trial.
Yao Lin +14 more
wiley +1 more source
Personalizing chronotherapy of immune checkpoint blockade. [PDF]
Ismail-Sutton S +5 more
europepmc +1 more source
Influence of the Immune Checkpoint Inhibitors on the Hemostatic Potential of Blood Plasma [PDF]
Irina Patalakh +5 more
openalex +1 more source
Cancer cell‐intrinsic cholesterol promotes the S‐palmitoylation of SP1, increasing its nuclear translocation and driving the transcription and secretion of MDK, which in turn facilitates the differentiation of macrophages into a lipid‐associated phenotype.
Shirong Peng +12 more
wiley +1 more source
Endothelial cells as targets of immune checkpoint blockade. [PDF]
Korman AJ, Taylor M, Stephen Hodi F.
europepmc +1 more source
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma [PDF]
Artyomov, Maxim N. +15 more
core +1 more source

